Literature DB >> 16262027

Entamoeba moshkovskii and Entamoeba dispar-associated infections in pondicherry, India.

Subhash Chandra Parija1, Krishna Khairnar.   

Abstract

The prevalence of Laredo strain--Entamoeba moshkovskii--and non-pathogenic E. dispar in patients attending the Jawaharlal Institute of Postgraduate Medical Education and Research hospital, Pondicherry, India, is reported here. E. moshkovskii is reported for the first time in India. The species are morphologically indistinguishable from pathogenic E. histolytica. Of 746 stool samples screened, 68 showing cyst or trophozoite stage of E. histolytica, E. dispar, or E. moshkovskii were subjected to small subunit (SSU) rRNA gene-based polymerase chain reaction, which revealed a higher prevalence of E. dispar (8.8%) and E. moshkovskii (2.2%) compared to E. histolytica (1.7%) in patients. Only 19% of the 68 stool samples, resembling E. histolytica by microscopy, were actually E. histolytica, implying that 81% of suspected infections were misdiagnosed and would have been treated unnecessarily with anti-amoebic drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16262027

Source DB:  PubMed          Journal:  J Health Popul Nutr        ISSN: 1606-0997            Impact factor:   2.000


  30 in total

1.  PCR detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from Sydney, Australia.

Authors:  R Fotedar; D Stark; N Beebe; D Marriott; J Ellis; J Harkness
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

Review 2.  Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.

Authors:  Jaco J Verweij; C Rune Stensvold
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

3.  Genotyping of Giardia lamblia and Entamoeba spp from river waters in Iran.

Authors:  Mohammad Reza Mahmoudi; Ehsan Nazemalhosseini-Mojarad; Panagiotis Karanis
Journal:  Parasitol Res       Date:  2015-09-09       Impact factor: 2.289

4.  Epidemiological, clinical, and diagnostic data on intestinal infections with Entamoeba histolytica and Entamoeba dispar among returning travelers.

Authors:  K-H Herbinger; E Fleischmann; C Weber; P Perona; T Löscher; G Bretzel
Journal:  Infection       Date:  2011-06-30       Impact factor: 3.553

5.  Gene migration for re-emerging amebiasis in Iran's northwest-Iraq borders: a microevolutionary scale for reflecting epidemiological drift of Entamoeba histolytica metapopulations.

Authors:  Asad Mohammadzadeh; Adel Spotin; Mahmoud Mahami-Oskouei; Ali Haghighi; Nozhat Zebardast; Kobra Kohansal
Journal:  Parasitol Res       Date:  2016-10-20       Impact factor: 2.289

6.  Entamoeba moshkovskii infections in Sydney, Australia.

Authors:  R Fotedar; D Stark; D Marriott; J Ellis; J Harkness
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-24       Impact factor: 3.267

7.  Human amebiasis: breaking the paradigm?

Authors:  Cecilia Ximénez; Rene Cerritos; Liliana Rojas; Silvio Dolabella; Patricia Morán; Mineko Shibayama; Enrique González; Alicia Valadez; Eric Hernández; Olivia Valenzuela; Angélica Limón; Oswaldo Partida; Edwards F Silva
Journal:  Int J Environ Res Public Health       Date:  2010-03-16       Impact factor: 3.390

8.  Molecular epidemiology of amebiasis.

Authors:  Ibne Karim M Ali; C Graham Clark; William A Petri
Journal:  Infect Genet Evol       Date:  2008-05-14       Impact factor: 3.342

Review 9.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

10.  Detection of Entamoeba histolytica DNA in the saliva of amoebic liver abscess patients who received prior treatment with metronidazole.

Authors:  Krishna Khairnar; Subhash Chandra Parija
Journal:  J Health Popul Nutr       Date:  2008-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.